Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant(2008).„Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”.Annual Reports in Computational Chemistry4: 217-241.DOI:10.1016/S1574-1400(08)00012-1.
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP.(2012).„ChEMBL: a large-scale bioactivity database for drug discovery”.Nucleic Acids Res40(Database issue): D1100-7.DOI:10.1093/nar/gkr777.PMID21948594.edit
Loscalzo LM, Wasowski C, Paladini AC, Marder M(February 2008).„Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines”.Eur. J. Pharmacol.580(3): 306–13.DOI:10.1016/j.ejphar.2007.11.011.PMID18048026.
Guzmán-Gutiérrez SL, Navarrete A(March 2009).„Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers”.Planta Med.75(4): 295–301.DOI:10.1055/s-0029-1185306.PMID19219759.
Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C(April 2003).„Interaction between flavonoids and the blood-brain barrier: in vitro studies”.J. Neurochem.85(1): 180–92.DOI:10.1046/j.1471-4159.2003.01652.x.PMID12641740.
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP.(2012).„ChEMBL: a large-scale bioactivity database for drug discovery”.Nucleic Acids Res40(Database issue): D1100-7.DOI:10.1093/nar/gkr777.PMID21948594.edit
Hirata A, Murakami Y, Shoji M, Kadoma Y, Fujisawa S(2005).„Kinetics of radical-scavenging activity of hesperetin and hesperidin and their inhibitory activity on COX-2 expression”.Anticancer Res.25(5): 3367–74.PMID16101151.
Monforte MT, Trovato A, Kirjavainen S, Forestieri AM, Galati EM, Lo Curto RB(September 1995).„Biological effects of hesperidin, a Citrus flavonoid. (note II): hypolipidemic activity on experimental hypercholesterolemia in rat”.Farmaco50(9): 595–9.PMID7495469.
Ohtsuki K, Abe A, Mitsuzumi H, et al.(December 2003).„Glucosyl hesperidin improves serum cholesterol composition and inhibits hypertrophy in vasculature”.J. Nutr. Sci. Vitaminol.49(6): 447–50.PMID14974738.
Emim JA, Oliveira AB, Lapa AJ(February 1994).„Pharmacological evaluation of the anti-inflammatory activity of a citrus bioflavonoid, hesperidin, and the isoflavonoids, duartin and claussequinone, in rats and mice”.J. Pharm. Pharmacol.46(2): 118–22.PMID8021799.
Galati EM, Monforte MT, Kirjavainen S, Forestieri AM, Trovato A, Tripodo MM(November 1994).„Biological effects of hesperidin, a citrus flavonoid. (Note I): antiinflammatory and analgesic activity”.Farmaco40(11): 709–12.PMID7832973.
Loscalzo LM, Wasowski C, Paladini AC, Marder M(February 2008).„Opioid receptors are involved in the sedative and antinociceptive effects of hesperidin as well as in its potentiation with benzodiazepines”.Eur. J. Pharmacol.580(3): 306–13.DOI:10.1016/j.ejphar.2007.11.011.PMID18048026.
Guzmán-Gutiérrez SL, Navarrete A(March 2009).„Pharmacological exploration of the sedative mechanism of hesperidin identified as the active principle of Citrus sinensis flowers”.Planta Med.75(4): 295–301.DOI:10.1055/s-0029-1185306.PMID19219759.
Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C(April 2003).„Interaction between flavonoids and the blood-brain barrier: in vitro studies”.J. Neurochem.85(1): 180–92.DOI:10.1046/j.1471-4159.2003.01652.x.PMID12641740.